Laverne Hoover
Internal Medicine · Cullman, ALNPI 1922051465
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 217 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 20.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $930 and has fallen 97.1% since, to $27 in 2023.
Across 217 payments — averaging $15.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$686
- Pfizer$587
- AstraZeneca$307
- AbbVie$263
- Johnson & Johnson$187
- Astellas Pharma US Inc$154
- plus $1K from 23 others
What the payments were for
- Food & beverage$3,279100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 47 | $686 |
| Pfizer | 48 | $587 |
| AstraZeneca | 6 | $307 |
| AbbVie(2 entities) | 17 | $263 |
| Johnson & Johnson | 13 | $187 |
| Astellas Pharma US Inc | 10 | $154 |
| E.r. Squibb & Sons, L.L.C. | 11 | $137 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $130 |
| Amgen(2 entities) | 8 | $110 |
| CSL Behring | 5 | $93 |
| GSK | 4 | $60 |
| Boehringer Ingelheim | 4 | $53 |
| Novartis | 3 | $48 |
| Xeris Pharmaceuticals, Inc. | 3 | $48 |
| Amarin Pharma, Inc. | 3 | $45 |
| Ironwood Pharmaceuticals, Inc | 3 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $42 |
| Merck | 3 | $40 |
| Nestle Healthcare Nutrition Inc. | 3 | $38 |
| Eisai Inc. | 3 | $35 |
| Corcept Therapeutics | 2 | $32 |
| Esperion Therapeutics, Inc. | 2 | $31 |
| Currax Pharmaceuticals LLC | 2 | $29 |
| Radius Health, Inc. | 1 | $16 |
| Seqirus USA Inc | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $13 |
| Circassia Inc. | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
| Lilly USA, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$157
- BREZTRI AEROSPHERE$157
How this compares
$3,279 in reported general payments places this provider in the 80th percentile of 1,533 internal medicine providers in Alabama.
Other internal medicine in Cullman
- Ryan WeldonBirmingham$458K
- Thomas McKelveyMobile$365K
- Mary HonkanenMobile$302K
- Robert LewisBirmingham$187K
- Rosalind BowlesGadsden$168K
- Sonja PettusJasper$117K
- Bobby WrightsMobile$89K
- Thomas HuddleBirmingham$76K
- Rahel AzizMobile$67K
- Justin HoveyDothan$67K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.